MedTrace Logo

Efficacy Assessment of Probiotics in Improving Sleep Indices

NCT06361368 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2024-05-13

No results posted yet for this study

Summary

To determine whether PS150 (1) reduces insomnia symptoms, (2) improves sleep quality, (3) adjusts autonomic nervous system functioning, (4) reduces the severity of anxiety and depressive symptoms, and (5) adjusts microbiome and endocrine functions.

Conditions

Interventions

DIETARY_SUPPLEMENT

PS150

Participants took one capsule with PS150 after dinner for 30 days.

DIETARY_SUPPLEMENT

Placebo

Participants took one capsule with placebo after dinner for 30 days.

Sponsors & Collaborators

  • Bened Biomedical Co., Ltd.

    collaborator INDUSTRY

  • National Yang Ming Chiao Tung University

    lead OTHER

Principal Investigators

  • Cheryl C Yang, doctor · Institute of Brain Science ,National Yang Ming Chiao Tung University, Taipei City, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-11
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06361368 on ClinicalTrials.gov